Skip to main content Skip to navigation
Menu
800-789-7366

Health Alert:

Coronavirus Information: Vaccinations | Testing | Safety Policies & Visitor Guidelines | Appointments & Scheduling | FAQs

Schedule a COVID vaccine appointment

Schedule a COVID vaccine appointment: call us 8am to 5pm, Monday through Friday, at 267-758-4902.

Ahmara G. Ross, MD, PhD

Ophthalmology
Ahmara G. Ross, MD, PhD
4.9 with 72 ratings

Sees Young Adolescents (ages 12-14), Older Adolescents (ages 15-18), Adults (18-65), Geriatrics (65+)

Ahmara G. Ross, MD, PhD

Ophthalmology
4.9 with 72 ratings

Sees Young Adolescents (ages 12-14), Older Adolescents (ages 15-18), Adults (18-65), Geriatrics (65+)

  • Assistant Professor of Ophthalmology at the Hospital of the University of Pennsylvania
  • Assistant Professor of Neurology
  • Dr. Ross is a Penn Medicine physician.
Accepting new patients
Call 800-789-7366 Request Callback

Meet Dr. Ross

Dr. Ross is an Assistant Professor of Ophthalmology and Neurology who completed ophthalmology residency at the University of Pittsburgh then fellowships in Neuro-ophthalmology and Glaucoma at the Scheie Eye Institute, University of Pennsylvania. She also has a PhD from Thomas Jefferson University. In addition to caring for patients with both glaucoma and neuro-ophthalmologic disorders, she also performs ocular surgery ranging from cataracts, minimally invasive, and incisional glaucoma surgery.

Dr. Ross diagnoses, treats, and manages optic neuropathies beyond the spectrum of glaucoma, but views this disease as another neuro-degenerative disease in need for sight changing therapy. Her interests and professional strengths go beyond basic science research with a clinical approach also aimed at addressing socio-economic barriers to the treatment of healthcare.

She joined the faculty in 2017 and is currently funded by an NIH K08 Career Development award to investigate the neuroprotective potential of gene therapy directed at retinal ganglion cells and neighboring support cells to treat chronic glaucoma. She is also collaborating on similar research using gene therapy to treat other mouse models of optic neuropathy such as trauma, compression, and inflammation.

Back To Top